0281: Phase I/Ii Dose-Escalation Trial of Patupilone Every 3 Weeks in Patients with Platinum-Resistant/Refractory Ovarian Cancer

W. W. ten Bokkel Huinink; W. M. Smit; J. Sufliarsky; D. S. Di-Zon; A. M. Oza; J. M. Cuillerot; K. J Williams; A. R. Johri

doi:10.1136/ijgc-00009577-200610001-00281

Article info

ABSTRACT: Poster Session 1: Ovarian – Sunday, October 15, 2006

0281: Phase I/Ii Dose-Escalation Trial of Patupilone Every 3 Weeks in Patients with Platinum-Resistant/Refractory Ovarian Cancer

Authors

W. W. ten Bokkel Huinink Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam PubMed articles Google scholar articles
W. M. Smit Department of Medical Oncology, Medisch Spectrum Twente, Enschede, The Netherlands PubMed articles Google scholar articles
J. Sufliarsky Department of Medicine, National Cancer Institute, Bratislava, Slovack Republic PubMed articles Google scholar articles
D. S. Di-Zon Department of Obstetrics and Gynecology, Women and Infants' Hospital, Providence, USA PubMed articles Google scholar articles
A. M. Oza Clinical Studies Resource Centre, Princess Margaret Hospital, Toronto, Canada PubMed articles Google scholar articles
J. M. Cuillerot BU-Oncology, Novartis Pharma AG, Basel, Switzerland PubMed articles Google scholar articles
K. J Williams Novartis Oncology Business Unit, Novartis Pharma AG, Basel, Switzerland PubMed articles Google scholar articles
A. R. Johri Oncology Clinical Research, Novartis Pharmaceuticals Corporation, East Hanover, USA PubMed articles Google scholar articles

Citation

Huinink WWTB, Smit WM, Sufliarsky J, et al

0281: Phase I/Ii Dose-Escalation Trial of Patupilone Every 3 Weeks in Patients with Platinum-Resistant/Refractory Ovarian Cancer

International Journal of Gynecologic Cancer 2006;16:680.

Online issue publication

December 03, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password